The Petri Dish: Flagship startup hires GSK leader; Biogen cuts digital health group

Also, almost two years after it agreed to buy Lexington-based Dicerna Pharmaceuticals Inc. for $3.3 billion, Novo Nordisk has scored its first drug approval from the acquisition. Here’s news from the life sciences you may have missed.